CHOSA Oncology Agrees With CLIA Lab on Platin-DRP US Commercialization

The company agreed with a CLIA-certified laboratory to develop and validate Platin-DRP. It expects first revenue in summer 2027, subject to successful analytical validation and implementation under the laboratory’s CLIA certification.